2-mercaptomethyl-3-guanidinoethylthiopropionic acid has been researched along with ubenimex in 4 studies
| Studies (2-mercaptomethyl-3-guanidinoethylthiopropionic acid) | Trials (2-mercaptomethyl-3-guanidinoethylthiopropionic acid) | Recent Studies (post-2010) (2-mercaptomethyl-3-guanidinoethylthiopropionic acid) | Studies (ubenimex) | Trials (ubenimex) | Recent Studies (post-2010) (ubenimex) |
|---|---|---|---|---|---|
| 44 | 0 | 2 | 930 | 43 | 182 |
| Protein | Taxonomy | 2-mercaptomethyl-3-guanidinoethylthiopropionic acid (IC50) | ubenimex (IC50) |
|---|---|---|---|
| Aminopeptidase B | Rattus norvegicus (Norway rat) | 6 | |
| M1 family aminopeptidase | Plasmodium falciparum FcB1/Columbia | 0.284 | |
| Cytosol aminopeptidase | Bos taurus (cattle) | 1.0005 | |
| 72 kDa type IV collagenase | Homo sapiens (human) | 6.45 | |
| Leukotriene A-4 hydrolase | Homo sapiens (human) | 1.4742 | |
| Aminopeptidase N | Homo sapiens (human) | 2.6333 | |
| Aminopeptidase N | Sus scrofa (pig) | 3.8211 | |
| Angiotensin-converting enzyme | Rattus norvegicus (Norway rat) | 2.7 | |
| Puromycin-sensitive aminopeptidase | Homo sapiens (human) | 3.5 | |
| Bacterial leucyl aminopeptidase | Vibrio proteolyticus | 1.0005 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, KL; Cunoosamy, MP; Robertson, MJ | 1 |
| Batt, CM; Hanesworth, JM; Harding, JW; Jensen, LL; Wright, JW | 1 |
| Bausback, HH; Churchill, L; Palmieri, FE; Ward, PE | 1 |
| Guimarães, JA; Maack, T; Moreira, MF; Vieira, MA | 1 |
4 other study(ies) available for 2-mercaptomethyl-3-guanidinoethylthiopropionic acid and ubenimex
| Article | Year |
|---|---|
Effects of peptidase inhibition on angiotensin receptor agonist and antagonist potency in rabbit isolated thoracic aorta.
Topics: 3-Mercaptopropionic Acid; Adrenergic alpha-Agonists; Amino Acid Sequence; Aminopeptidases; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Aorta, Thoracic; Dose-Response Relationship, Drug; In Vitro Techniques; Leucine; Male; Molecular Sequence Data; Muscle Contraction; Oligopeptides; Peptides; Phenylephrine; Rabbits; Receptors, Angiotensin; Vasoconstriction | 1992 |
Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels.
Topics: 3-Mercaptopropionic Acid; Angiotensin II; Angiotensin III; Animals; Anti-Bacterial Agents; Blood Pressure; Carboxypeptidases; Cerebral Ventricles; Injections, Intraventricular; Leucine; Male; Oligopeptides; Peptides; Protease Inhibitors; Radioimmunoassay; Rats; Rats, Inbred Strains | 1990 |
Kinin and enkephalin conversion by an endothelial, plasma membrane carboxypeptidase.
Topics: 3-Mercaptopropionic Acid; Animals; Carboxypeptidases; Cell Membrane; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Edetic Acid; Endothelium; Enkephalins; Glycopeptides; Hydrogen-Ion Concentration; Kinetics; Kinins; Leucine; Lysine Carboxypeptidase; Microscopy, Phase-Contrast; Muscle, Smooth, Vascular; Phenanthrolines; Puromycin; Swine | 1986 |
Conversion of T-kinin to bradykinin by the rat kidney.
Topics: 3-Mercaptopropionic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Carboxypeptidases; Kidney; Leucine; Male; Perfusion; Rats; Rats, Wistar | 1994 |